AKT1 and Alzheimer disease: In an AD rat model, naringenin treatment at 25, 50, and 100 mg/kg improved spatial learning and memory by regulating the PI3K/Akt/GSK-3β pathway and inhibiting tau hyperphosphorylation [157].